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ARTICLE
Cytotoxic T cells are able to efficiently eliminate
cancer cells by additive cytotoxicity
Bettina Weigelin 1,2,3,4✉, Annemieke Th. den Boer5, Esther Wagena1, Kelly Broen6, Harry Dolstra6,
Rob J. de Boer 7, Carl G. Figdor 8, Johannes Textor8 & Peter Friedl 1,2,9✉
Lethal hit delivery by cytotoxic T lymphocytes (CTL) towards B lymphoma cells occurs as a
binary, “yes/no” process. In non-hematologic solid tumors, however, CTL often fail to kill
target cells during 1:1 conjugation. Here we describe a mechanism of “additive cytotoxicity”
by which time-dependent integration of sublethal damage events, delivered by multiple CTL
transiting between individual tumor cells, mediates effective elimination. Reversible sublethal
damage includes perforin-dependent membrane pore formation, nuclear envelope rupture
and DNA damage. Statistical modeling reveals that 3 serial hits delivered with decay intervals
below 50min discriminate between tumor cell death or survival after recovery. In live mel-
anoma lesions in vivo, sublethal multi-hit delivery is most effective in interstitial tissue where
high CTL densities and swarming support frequent serial CTL-tumor cell encounters. This
identifies CTL-mediated cytotoxicity by multi-hit delivery as an incremental and tunable
process, whereby accelerating damage magnitude and frequency may improve immune
efficacy.
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Cytotoxic T lymphocytes (CTLs) execute effector functionby a cyclic process of transient cell–cell interaction andparacrine delivery of cytotoxic effector molecules to target
cells, followed by target cell death1,2. CTL and natural killer (NK)
cells can bind to and attack more than one target cell
sequentially3–5. As a consequence of multi-hit delivery, single
CTLs are capable of eliminating multiple antigenic target cells
in vitro and in vivo, ranging from 1 up to 20 kills per CTL and
day, as estimated from bulk killing assays and mathematical
modeling6,7. Such high efficacy of CTL-mediated serial killing,
however, is rarely observed in patients receiving adoptive transfer
of tumor-specific T cell receptor (TCR)-engineered or chimeric
antigen receptor (CAR) T cells8. Evidence for effective serial
target cell killing after 1 : 1 pairings has further not been obtained
in antigenic solid tumor models in mice where CTLs were found
to form predominantly short-lived interactions with target cells,
which rarely result in direct apoptosis induction9–13. Beyond
tumor models, non-productive CTL interactions and failed target
cell eradication are also observed in alloimmune response against
transplants14 and murine cytomegalovirus-infected cells in the
mouse dermis15. Consequently, the physiological relevance of
CTL contacts, which—individually—fail to induce target cell
death remains unclear.
Preclinical and emerging clinical data indicate that successful
CTL effector function correlates with high local CTL
densities16,17. CTL density control of killing efficacy has further
been proposed by mathematical modeling based on bulk three-
dimensional (3D) killing assays18. Different mechanisms have
been proposed how high CTL densities may mediate effective
killing. High CTL densities enable high contact frequencies and
multiple CTL–tumor cell encounters. This may increase the
likelihood of multiple CTL simultaneously attacking a single
target cell19,20 and the probability for tumor cells to be contacted
by rare potent CTL18. In addition, cytotoxic cytokine release,
including interferon-γ (IFNγ) and tumor necrosis factor, is
positively associated with high-density T cell infiltration21.
However, whether individually ineffective CTL interactions in
solid tumors can become effective at high CTL density and by
which mechanism individually “ineffective” contacts contribute to
target cell killing remains to be investigated.
Here we apply live-cell microscopy in vitro and in vivo, introduce
molecular damage reporters into antigenic tumor cells, and analyze
the types, temporal mechanisms, and thresholds of damage induced
in antigenic tumor cells by “seemingly ineffective” CTL contacts.
These data indicate that individually ineffective CTL contacts
induce sublethal damage, which becomes integrated over time in
the target cell until apoptosis is induced. Through a multi-hit
mechanism, CTL induce tumor cell death when density is high,
whereas tumor cells repair sublethal damage and survive when CTL
density is low. The mechanism of “additive cytotoxicity” explains
how individually ineffective interactions become effective at high
CTL density and can be utilized to improve therapy success by
microenvironmental or immune modulation.
Results
CTL serial conjugation and effector function. In vitro-activated
chicken ovalbumin (OVA)-specific OT1 CTLs were confronted
with transformed mouse embryonic fibroblasts expressing the
OVA peptide (MEC-1/OVA) and the co-stimulatory molecule
B7.122,23. In contrast to tumor cells that evolved in vivo, this
engineered model lacks natural immune escape modifications
(e.g., downregulation of major histocompatibility complex-I or
apoptosis resistance) and, thus, represents an idealized model for
maximized CTL efficacy at a single cell level. After 30 h of co-
culture, killing efficacy was near 100% at high effector–target (ET)
ratios and reached background level below ET ratios of 1 : 128
(Supplementary Fig. 1a). To assess the serial killing efficacy of
individual CTL, we analyzed antigen-specific CTL–target cell
interactions and outcome in long-term time-lapse microscopy
recordings by tracing individual CTL during interaction with
target cells. The duration of individual CTL–target cell interac-
tions was variable (lasting minutes to hours), with lag times
between initial CTL binding and target cell death lasting
1.8 ± 1.5 h, and was followed by a subsequent period of ongoing
CTL engagement with the dead cell body (“necrophilic phase”)
(Supplementary Fig. 1b–e). This extended lag phase until apop-
tosis differs from lag phases obtained for CTL-mediated killing of
target cells from leukocyte lineages, lasting <5–25 min24–26. In
regions of low local CTL density, sequential contacts by an
individual CTL resulted in the serial killing of multiple neigh-
boring target cells (Fig. 1a). On the population level, 50% of the
CTL acted as serial killers (maximum of 11 killed target cells/
24 h), whereas a small CTL subset (15%) repeatedly contacted
target cells without inducing apoptosis (Supplementary Fig. 1f).
The percentage of CTL with killing capacity correlated with the
surface expression of LAMP-1 by 85–90% of CTL, indicating
recognition of the target cells and lytic vesicle exocytosis by the
majority of CTL (Fig. 1b and Supplementary Fig. 1g). The lag
phase to apoptosis was neither compromised nor accelerated over
consecutive killing events (Fig. 1c), which resulted in a consistent
eradication frequency of 1 kill every 2 h (Supplementary Fig. 1h).
This excludes gain of cytotoxicity by kinetic priming through
repetitive antigenic interactions. Thus, OT1 CTL serially elim-
inate highly immunogenic target cells over 24 h and in a non-
exhaustive manner.
CTL induce sublethal plasma membrane damage. To compare
effector function against solid tumor cells, which typically retain
resistance to CTL-mediated killing, OT1 CTL were confronted
with mouse melanoma B16F10 cells expressing the OVA peptide
(B16F10/OVA) (Supplementary Fig. 2a–d and Supplementary
Movie 1). As a second model, interleukin-2 (IL-2)-activated
human SMCY.A2 CTL27, which recognize an HLA-A2-restricted
antigen encoded on the y chromosome, were confronted with
male human melanoma cell lines BLM or MV3 (Supplementary
Fig. 2e–i and Supplementary Movie 1). Compared to the MEC-1/
OVA cells, these three melanoma models show delayed, but
ultimately effective target cell elimination at the assay endpoint
after 24 h, whereas OVA-negative B16F10 or female MCF-7 cells
survived (Fig. 1d). Thus, the endpoints of both mouse and human
models for probing CTL effector function show comparable target
cell elimination in 3D culture. Notably, across all cell types tested,
only a minority of individual CTL–target cell contacts induced
apoptosis at first encounter, whereas 60–70% (MEC-1/OVA,
BLM) or >90% (B16F10/OVA, MV3) of individual conjugations
were followed by target cell survival (Fig. 1e).
CTL degranulation induces transient perforin-mediated pores
in the target cell membrane, which facilitates diffusion of
extracellular factors into the target cell, including CTL-derived
granzyme B28. OT1 CTL deficient in perforin expression failed to
kill B16F10/OVA cells in organotypic culture (Supplementary
Fig. 2j), whereas CTL effector function remained intact after
interference with Fas–FasL interaction (Supplementary Fig. 2k).
Further, adding perforin-deficient OT1 CTL to a fixed number of
wt OT1 CTL did not increase killing efficiency, indicating that
perforin-independent mechanisms delivered by excess CTL,
including soluble mediators, do not induce or enhance cytotoxi-
city against B16F10/OVA cells (Supplementary Fig. 2l). Thus,
elimination of B16F10/OVA cells by OT1 CTL in 3D culture
critically depends on perforin.
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To visualize perforin pore formation and to discriminate
sublethal cytotoxic hits from functionally inert interactions, MEC-
1/OVA and B16F10/OVA cells were engineered to express the
calcium sensor GCaMP6s29, and were monitored for transient
Ca2+ influx, as a proxy for perforin pore formation and recovery30
(Fig. 2a1, Supplementary Fig. 3a, and Supplementary Movie 2).
Ca2+ influx induction was strictly dependent on perforin
expression in OT1 cells (Fig. 2b; “perforin events”) and the
Ca2+ signal originated at CTL–tumor cell contact region differed
in signal intensity and duration from unspecific intracellular Ca2+
fluctuations (Supplementary Fig. 3b1 and b2, c). A substantial
fraction (40%) of antigen-specific but nonlethal CTL–target cell
contacts showed CTL-associated perforin events in B16F10/OVA
cells (Fig. 2b), which were transient (median: 30 s; Fig. 2c) and in
90% followed by target cell survival (Fig. 2d).
To test whether the variability of perforin events in B16F10/OVA
cells were a consequence of heterogeneous TCR engagement, we
quantified Ca2+ signaling in CTL upon target cell contact. OT1
CTL showed comparably high rates of Ca2+ signaling when
contacting MEC-1/OVA and B16F10/OVA cells (80–85%), typi-
cally within seconds after contact initiation (Fig. 3a). When co-
registered with perforin events in target cells, 40% of Ca2+ positive
CTL contacts with B16F10/OVA coincided with or were immedi-
ately followed by a perforin event in the target cell (Fig. 3b, c). In
conclusion, although TCR triggering in OT1 CTL occurs reliably,
the induction of perforin events in the target cell varied.
CTL-induced structural damage in target cells. To address
whether transient perforin pores were associated with structural
intracellular damage, B16F10/OVA cells were engineered to
express green fluorescent protein tagged with a nuclear localiza-
tion signal (NLS-GFP)31 or 53BP1trunc-Apple32. NLS-GFP
leakage into the cytoplasm was detected in 25% of CTL–target
cell contacts and was absent when CTL lacked perforin expres-
sion (Fig. 2a2, b, Supplementary Fig. 3d–g, and Supplementary
Movie 3). Recovery, as indicated by diminishing NLS-GFP signal
in the cytosol and recovery in the nucleus, occurred in 75% of
events within minutes to hours (median: 49 min; Fig. 2c, d).
53BP1 initiates DNA damage repair complexes, which can be
visualized as repair foci by 53BP1trunc-Apple32 (Supplementary
Fig. 3h and Supplementary Movie 4). 53BP1 foci were induced in
35% of CTL contacts, in dependence of perforin expression in
OT1 CTL (Fig. 2a3, b) and CTL density (Supplementary Fig. 3i,
j). CTL-induced 53BP1 foci persisted for several hours (median:
4 h) and were resolved in 73% of events (Fig. 2c, d). These data
indicate that CTL contacts induce reversible sublethal damage to
the nuclear lamina and DNA.
Death induction by multiple CTL. Across all tested tumor
models, sequential or simultaneous contacts by multiple CTL
with the same target cell occurred before target cell death
(Fig. 4a). In the B16F10 model, >90% of successful kills were
preceded by two to nine CTL encounters by distinct CTLs
Fig. 1 CTL serial conjugation and effector function in different tumor models. a Time-lapse sequence and migration track of one OT1 CTL killing seven
MEC-1/OVA target cells sequentially within 11 h. Circles, CTL; cross, apoptotic target cell; scale bar, 20 µm. Representative example of a serial killer CTL
derived from analysis of 43 CTL pooled from 8 independent experiments). b Lamp-1 expression at the surface of OT1 CTL after 24 h of 3D co-culture with
MEC-1/OVA cells. Representative example from three independent experiments. c Lag phase until apoptosis of consecutive single interaction kills by the
same CTL (43 CTL from 8 independent experiments). Red bars, median. p-Value, Kruskal–Wallis test. d Population survival of four antigen-dependent
mouse and human target, and three control cell lines. Quantifications from three independent experiments for each cell line. B16F10, 98 cells; B16F10/OVA,
31 cells; MEC-1, 57 cells; MEC-1/OVA, 32 cells; BLM, 28 cells; MV3, 18 cells; MCF-7, 102 cells. e Inefficiency of inducing apoptosis by individual CTL
contacts in OT1 and SMCY.A2 CTL models. Error bars, mean ± SD obtained from 104 MEC-1/OVA, 183 B16F10/OVA, 53 BLM, and 50 MV3 contacts from
N= 5 (MEC-1/OVA, B16F10/OVA) or 3 (BLM, MV3) independent experiments per cell model. Source data are provided as a Source Data file.
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(Fig. 4b). When co-registered over time for each target cell, death
induction was preceded by serial perforin events with variable
onset and frequency between hits. The lag time between contact
initiation and first perforin event was 6 min in MEC-1/OVA cells
and 16 min in B16F10/OVA cells (Fig. 4c). Killing of the MEC-1/
OVA cells was preceded by perforin events with 4 min median
interval, whereas perforin events in B16F10/OVA cells occurred
with longer intervals of 18 min (Fig. 4d). Although >50% of
contacts induced only one perforin event in B16F10/OVA cells, in
40% of CTL contacts yielded at least two sequential perforin
Fig. 2 Type and kinetics of sublethal damage induced by CTL. a Reporter strategies. Green horizontal bars, duration of CTL contacts. Panel 1: CTL-
mediated perforin pores visualized as Ca2+ influx into B16F10/OVA target cells using the GCaMP6s reporter. Time-resolved intensity plot of GCaMP6s
event in the target cell cytosol followed by survival. Green, OT1 CTL (GFP); Fire LUT, Ca2+ level (GCaMP6s). Panel 2: CTL-mediated structural damage of
the nuclear lamina monitored as NLS-GFP leakage into the cytosol. Nuclear and cytosolic GFP intensity plotted over time. Green, NLS-GFP; red: Histone-2B-
mCherry; arrowhead: monitored cell. Asterisks, nuclear leakage events. Panel 3: CTL-mediated DNA damage response plotted as 53BP1trunc-Apple
focalization in the nucleus over time. Fire LUT, 53BP1trunc-Apple. Insets, zooms of reversibility of 53BP1 foci. Scale bars, 10 µm. Image sequences in panels
1 and 2 show representative examples from experimental datasets shown in b–d. b Percentage of contacts of wt and perforin-deficient CTL with B16F10/
OVA cells inducing Ca2+ events, NLS-GFP cytosolic leakage, and 53BP1trunc-Apple foci in target cells. Data show the mean ± SD from N= 3 (GCaMP6s/
wt, NLS-GFP/wt/prf1−/−), 5 (53BP1trunc-Apple/wt), and triplicate movies from 1 (GCaMP6s/prf1−/−, NLS-GFP/prf1−/−) independent experiments. p-
Values, two-tailed Mann–Whitney test comparing wt and prf1−/− datasets. c Recovery times from initiation to termination of GCaMP6s, NLS-GFP, and
53BP1trunc-Apple reporter activity. Data show the medians with whiskers from minimum to maximum values derived from N= 32 (53BP1trunc-Apple), 40
(NLS-GFP), and 71 (GCaMP6s) individual events pooled from 3 (NLS-GFP, GCaMP6s) and 5 (53BP1trunc-Apple) independent experiments. p-Value,
Kruskal–Wallis test comparing all groups corrected by Dunn’s multiple comparisons test. d Percentage of cells with sublethal damage event, which fully
resolved. Data show the mean ± SD (five independent experiments per reporter) for an 1:2 ET ratio. Source data are provided as a Source Data file.
Fig. 3 Correlation between CTL Ca2+ signaling and perforin pore formation in different target cells. a Percentage of CTL contacts associated with Ca2+
events in OVA-expressing target cells (OVA) compared to OVA-negative parental (par) cells. Data show the means ± SD from three independent
experiments. b Image sequence of Fura2-labeled OT1 CTL during contact with GCaMP6s-expressing B16F10/OVA cell. Arrowheads: green, Fura2-positive
event; yellow, GCaMP6s-positive event. Scale bar, 10 μm. c Percentage of contacts triggering Ca2+ events in OT1 CTL or B16F10/OVA target cells,
respectively. Quantification (means and SD) was performed by manual analysis from 78 contacts pooled from N= 4 independent experiments. Source data
are provided as a Source Data file.
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events (Fig. 4e). Thus, compared to MEC-1/OVA cells, delayed
killing of B16F10/OVA cells correlated with delayed delivery of
perforin events (Fig. 4f).
Additive cytotoxicity. We then addressed whether apoptosis
could have been induced by rare deadly CTL hits (“stochastic
killing”) or, instead, by sublethal contacts that add up over time
(“additive cytotoxicity”) (Fig. 5a and Supplementary Movies 2
and 5). Therefore, we analyzed whether the lethality of the final
hit was enhanced by, or independent of, previous perforin events
and plotted the lag time to apoptosis together with target cell
survival probability relative to the number of pre-final perforin
events. Target cells which received two or more hits prior to the
lethal one showed accelerated apoptosis induction, together with
a sharp decrease in survival probability (Fig. 5b and Supple-
mentary Fig. 4a, b). The dependence of the lag time to apoptosis
on prior CTL hits is expected when additive effects exists, but it is
inconsistent with the stochastic killing hypothesis. To explore
stochastic killing directly, we performed the same analysis on
simulated data, using randomly swapped times between hits and
between the last hit and apoptosis. Here, cell death induction was
gradual and neither the lag time to apoptosis nor the survival
probability was dependent on the number of prior hits (Fig. 5c).
To address how long sublethal events remain relevant, we
estimated the time required to repair the damage caused by a
single perforin event, using a Cox regression model based on
additive killing. This resulted in an estimated damage half-life of
56.7 min (95% confidence interval: 33.1–112.2) of single perforin
events to contribute to lethal outcome (Fig. 5d). This interval was
consistent with the recovery kinetics of nuclear lamina defects
(Fig. 2c). Using the Bayesian Information Criterion (BIC) to
compare model fits showed that the model which integrates serial
damage and decay explained the data better (BIC difference > 10)
than a model based on the number of perforin events alone.
To integrate timing and heterogeneity of damage, we extended
our model to allow for variable damage delivered by serially
engaging CTL. A multivariate Cox model shows that perforin
events associated with the last interacting CTL (hazard ratio: 3.7,
Wald’s test p < 10−7) and earlier CTL in contact (hazard ratio:
3.0, p= 0.001) are both important predictors of apoptosis. This
analysis shows no statistical benefit of distinguishing between last
and prior CTL, indicating that their integrated, additive effects are
relevant for target cell death. A simpler Cox model that considers
all CTL equally relevant is a more parsimonious description (as
indicated by the lowest BIC) of the data than models that focus
on the last interacting CTL alone (BIC difference: 6.6). In
addition, a model that assumes variable damage between prior
and last CTL contacts was inferior in explaining the data (BIC
difference: 2.8). Thus, from a statistical perspective, our current
data offers no support for the hypothesis that a rare lethal hit
leads to target cell elimination.
Further, the majority (60%) of single CTL interactions that
preceded target cell death were associated with multiple perforin
events (Supplementary Fig. 4c, d). This highlights that both single
and sequential CTL contacts can deliver multiple perforin hits.
When co-registered, prolonged duration of interactions corre-
lated with an increased number of delivered perforin events for
either lethal or nonlethal outcome (Supplementary Fig. 4e). In
Fig. 4 Kinetics and frequency of CTL-induced sublethal events. a Percentage of apoptosis events preceded by multiple or single CTL contacts in mouse
and human melanoma models. Pooled data representing ≥100 contacts from ≥3 independent experiments per cell line. b Percentage of CTL engaged
before target cell death in B16F10/OVA co-culture with OT1 CTL. c Lag phase until first Ca2+ event after contact initiation in MEC-1/OVA and B16F10/
OVA target cells. Data from 55 (B16F10) and 52 (MEC-1) Ca2+ events. p-Value, two-tailed Mann–Whitney test. d Intervals between sequential Ca2+
events in the target cell induced by the same CTL in one single contact. Medians were 4min (MEC-1/OVA) and 18min (B16F10/OVA). Red line, median.
Data show 53 (B16F10) and 119 (MEC-1) Ca2+ events. p-Value, two-tailed Mann–Whitney test. e Number of Ca2+ events associated with the same CTL.
Data show 55 (B16F10) and 36 (MEC-1) CTL. Data from b to d pooled from three (B16F10) and two (MEC-1) independent experiments. p-Values, two-
tailed Mann–Whitney test. f Number of Ca2+ events per CTL contact plotted against frequency of sequential Ca2+ events in MEC-1/OVA cells compared
to the B16F10/OVA cells. Data from 53 (B16F10) and 119 (MEC-1) Ca2+ events pooled from 3 (B16F10/OVA) and 2 (MEC-1/OVA) independent
experiments. Source data are provided as a Source Data file.
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aggregate, these results indicate that sequential sublethal events,
which are delivered by single or multiple CTL in a timely manner,
favor-efficient target cell killing.
Multi-hit delivery as a function of CTL density. To test whether
apoptosis induction under conditions of high CTL density
facilitated additive, multi-hit interactions or, instead, a higher
probability of lethal single-hit interactions of few CTL18, we
titrated CTL density and monitored individual CTL–target cell
interactions by time-lapse microscopy. At high CTL density (ET
1 : 2) target cell death was frequent and preceded by multiple CTL
interactions, whereas at low CTL density (ET 1 : 16) infrequent
apoptotic events were predominantly preceded by single-contact
engagements (Fig. 5e). The CTL density effect was not enhanced
by the addition of perforin-deficient CTL (Supplementary Fig. 2l).
This indicates that high CTL density (“swarming”) enables effi-
cient apoptosis induction by favoring serial perforin-dependent
hits, preferentially by different CTL, whereas the ineffective kill-
ing at low CTL density largely relies upon single encounters.
Sublethal hit delivery in vivo. We lastly addressed whether
multiple encounters by CTL mediate anti-tumor cytotoxicity
in vivo. Activated OT1 CTL were adoptively transferred into
C57BL/6J mice bearing intradermal B16F10 melanoma and
monitored longitudinally by intravital microscopy through a skin
window (Supplementary Fig. 5a, b). A single application of OT1
CTL caused a transient, dose-dependent growth delay of the OVA
antigen-expressing but not of control tumors (Supplementary Fig.
5c). B16F10 tumors invade the dermis as multi-cellular strands33.
Concomitantly, OT1 CTL first accumulated in the tumor per-
iphery and subsequently redistributed towards the invasive tumor
front (Fig. 6a). This resulted in local ET ratios of 1 : 1 along the
tumor–stroma interface, whereas ET ratios in the tumor core
remained below 1 : 250 (Supplementary Fig. 5d, e). To identify
where and by which contact mechanism eradication of tumor
cells was achieved, CTL contacts and outcome were mapped
using histone-2B/mCherry (H2B/mCherry) to detect nuclear
fragmentation in B16F10/OVA cells12. Despite comparable ET
ratios, high fragmentation rates occurred in the invasion niche
but not the tumor rim (Fig. 6b). In either zone, >95% of CTL
contacts were transient, short-lived (median duration 15 min),
and nonlethal but accumuulated over multiple contacts to contact
durations reaching 1 up to several hours (Fig. 6c). When aggre-
gated, >86% of apoptotic events were preceded by multiple CTL
contacts and a minority (<14%) by individual CTL conjugation
(Fig. 6d). In the tumor invasion niche, high local CTL density
coincided with confined migration along tissue structures with
enhanced speed compared to the main tumor mass (Supple-
mentary Fig. 6a, b). This supported frequent contacts to B16F10/
OVA cells with cumulative contact duration reaching >1 h and
nuclear fragmentation in tumor cells in a time-dependent manner
(Fig. 6e and Supplementary Movie 6).
To discriminate functional from non-functional, irrelevant
interactions, we analyzed the occurrence of CTL-mediated Ca2+
events using GCaMP6s-expressing tumors. Most Ca2+ events
(80%) in B16F10/OVA cells were associated with CTL contacts,
but rare without interacting CTL (Supplementary Fig. 6c, d). In
invasive tumor subregions with high apoptosis rates, both the
frequency of CTL contacts inducing Ca2+ events and the tumor
Fig. 5 Additive cytotoxicity and estimation of damage recovery half-life. a Time-lapse sequence and intensity plot of multiple Ca2+ events followed by
target cell apoptosis. Green fluorescence, OT1 CTL (dsRed); Fire LUT, Ca2+ intensity (GCaMP6s). Cross, target cell death; Scale bar, 20 µm. Image
sequence shows a representative example from 124 perforin events preceding N= 63 B16F10/OVA apoptosis events, pooled from 5 independent
experiments. b Survival probability of B16F10/OVA cells having received increasing numbers of Ca2+ events. c Simulation of stochastic apoptosis induction
by permutation of waiting times between Ca2+ events, survival, and lag times until apoptosis. p-Values in c, d, two-sided log rank test comparing all groups.
d Estimation of damage recovery half-life in B16F10/OVA after one single Ca2+ event by a statistical model that assumes additive killing (see “Methods”).
Point and error bar: damage half-life that is most consistent with the data and at 95% confidence interval. Data in b–d represent 124 perforin events related
to N= 63 B16F10/OVA apoptosis events, pooled from 5 independent experiments. e Killing efficacy of B16F10/OVA cells and percentage of preceding
single or multiple interacting CTL in dependence of ET ratio. Left panel, means and SD from N= 2 independent experiments; right panel, 110 contacts from
N= 4 independent experiments per ET ratio. Source data are provided as a Source Data file.
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cell fraction receiving multiple Ca2+ events were by fivefold
increased, compared to the non-invading tumor rim (Fig. 6g, h
and Supplementary Movies 7 and 8). Thus, in vivo eradication of
tumor regions by CTL is a function of local CTL density and
frequent sublethal interactions.
Discussion
When benchmarked against the reliable and near-deterministic
elimination of B cells24–26, CTL effector function against non-
hematological solid tumor cells is inefficient. Despite reliable CTL
activation by the OVA antigen, only a minority of individual
CTL–tumor cell contacts (~5%) achieves B16F10 melanoma cell
killing directly. Instead, 95% of the death events required a
sequence of sublethal hits, ideally at least three hits delivered with
<50 min recovery intervals in between. These results indicate that
CTL-mediated apoptosis induction is not a binary event but may
depend on the probabilistic accumulation of damage within the
target cell over time. CTL-induced additive cytotoxicity may,
hence, follow damage rules of other types of cell death, including
the accumulation of (i) DNA double-strand breaks during frac-
tionated low-dose irradiation34,35, (ii) nuclear damage events in
invading tumor cells moving through mechanically challenging
confinement31, or (iii) with much longer time integration,
Fig. 6 Additive cytotoxicity in live tumors detected by intravital multiphoton microscopy. a Time-dependent CTL accumulation along the tumor–stroma
interface. Red, nuclei B16F10/OVA cells; green: OT1 CTL. Lower panel, position of individual CTL. Representative example of one tumor. b Correlation of
CTL density and apoptotic frequency in tumor subregions. Data show 135 apoptosis events pooled from 8 independent mice. c Cumulative contact duration
and outcome of single or multiple CTL contacting B16F10/OVA cells. Data represent the median with whiskers from 25 to 75 percentile values.
d Frequency of apoptosis induction associated with single or multiple interacting CTL. Data in c, d represent N= 40 nonlethal and 37 apoptotic events from
150 h of movies pooled from 20 independent tumors. Error bars, mean ± SD. e Representative micrographs and quantification of serial engagements of
multiple CTL with B16F10/OVA cells and outcome. Red cross, target cell apoptosis. Ten target cells from one tumor. f Percentage of contacts between CTL
with B16F10/OVA cells and duration category in the invasion zone vs. tumor edge. g Images from time-lapse recordings of GCaMP6s activity in B16F10/
OVA target cells in distinct tumor subregions. Dotted circles indicate the example areas plotted for GCaMP6s intensity in the graph below. Image sequence
shows a representative example from the dataset analyzed in h, i. h Percentage of CTL contacts that induced one or more Ca2+ events in invasion zones vs.
CTL-rich subregions at the tumor edge. i Percentage of tumor cells receiving none, one, or more than one Ca2+ event within a cumulative observation time
of 3 h per tumor subregion. Data in f, h, i represent 228 contacts from N= 4 independent mice. Data in h, mean ± SD (3 positions per subregion from N= 3
independent mice). p-Value, two-tailed Mann–Whitney test. Scale bars e, g, 50 µm. Source data are provided as a Source Data file.
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somatic mutations preceding neurodegeneration36. We thus
suggest accumulating sublethal damage as the prevailing
mechanism of tumor cell eradication by antigen-specific CTL.
In OT1 CTL interactions with B16F10/OVA melanoma target
cells, subsequent to perforin-mediated pores in the plasma
membrane, we here identified nuclear envelope rupture and DNA
double-strand breaks as sublethal damage types. Nuclear envelope
proteins including B-type lamins, which form and mechanically
stabilize the nuclear lamina, are substrates of Granzyme B37.
Granzyme B further cleaves inhibitor of caspase-activated DNase
(CAD), resulting in the release of CAD, which translocates into
the nucleus and induces DNA double-strand breaks38. Impor-
tantly, rather than leading to cell death directly, CTL-induced
damage to both the nuclear lamina and DNA was typically
transient, reversible, and followed by tumor cell survival.
The entry of extracellular Ca2+ through perforin pores triggers
rapid membrane repair mediated by membrane delivery and
fusion of cytosolic vesicles at the damage site39,40. The recovery
times following intracellular structural damage, observed using
live-cell reporter systems in target cells, are in agreement with
repair processes after mechanical or chemical challenge, or
ionizing radio damage31,41,42. Following mechanical rupture, the
nuclear lamina becomes restored by an endosomal sorting com-
plexes required for transport-dependent manner within
30–90 min42. DNA double-strand breaks trigger DNA damage
response (DDR) pathways, which mediate DNA repair by non-
homologous end joining and homologous recombination, within
hours, followed by cell survival43. The data further suggest that
the strength of lethal hit delivery per CTL contact varies, as
indicated by variability in sublethal hit frequency and lethal vs.
nonlethal outcomes on a single CTL or target cell level. Such
variability may be caused by differences of perforin expression in
CTL, the varying strength of TCR signaling, CTL polarization,
and exocytosis efficiency, as well as uptake variability of granule
content by target cells44. Also, damage repair in the target cell
may vary, resulting in lethal outcome or survival despite similar
frequency and amount of received perforin events. Repair of
sublethal CTL hits may further strengthen or weaken target cell
susceptibility to subsequent hits, or induce mutations, not unlike
other damage and repair processes45,46.
The concept of “additive cytotoxicity” predicts that sequential,
sub-threshold damage events accumulate and induce target cell
death. The “cytotoxic dose,” expressed as the amount of damage
per time, may result from both the magnitude of each damage
event and the frequency of sequential hits (Supplementary Fig. 7).
Stabilizing contacts may thus promote CTL efficacy by increasing
their chance to deliver multiple sublethal hits during the same
interaction and become already effective in tumor subregions of
low CTL density. However, due to the transient nature of most
CTL–tumor cell interactions in vitro and in vivo10,12,47,48, the
median individual contact time per CTL of 15–30 min (Fig. 5c
and Supplementary Figs. 1c–e and 2b–d, g–i) may be insufficient
for death induction by most single interactions and, hence more
likely to be achieved by serially engaging CTL. Accordingly, in
solid tumors, CTL killing efficacy is strongly dependent of local
CTL density18 and on CTL migration capacity49, which jointly
mediate frequent sublethal rather than highly effective 1 : 1
pairings. Intracellular damage accumulation may further be
mediated by supramolecular attack particles, delivered by tran-
sient CTL and NK cell contacts, releasing autonomous cytotoxic
complexes on target cell surfaces50,51. Thus, CTL interactions
induce variably damaging events, which may become integrated
over time in the target cell until apoptosis is induced or recovery
achieved (Supplementary Fig. 7).
Besides accumulation of sublethal damage by CTL with iden-
tical TCR identity, additive cytotoxicity may result from CTL
with different TCR specificities, each delivering variable degree of
damage, raising the possibility of polyclonal cooperation during
the effector phase. Likewise, additive cytotoxicity may enable
cooperation of cytotoxic leukocytes with complementary target-
recognition strategies, such as CTL and NK cells52,53 or opsonin-
guided macrophages54. The requirement of high local density of
antigen-specific CTL for apoptosis induction may further provide
a “filter,” which limits cell death by accidental miss-targeted CTL.
This could, e.g., explain the occurrence of autoreactive CTL cir-
culating in the peripheral blood in humans at low frequency
without causing clinical effects of autoimmunity55,56. Additive
cytotoxicity may thus be a mechanism to fine-tune peripheral
immune effector function and limit unintended tissue damage by
autoimmunity.
The here established criteria for structural trauma in the
plasma membrane, nuclear envelope, and DNA, as well as the
metrics for frequency and timing of sublethal events, will aid a
classification of additive modules and mechanisms by which
immune stimulation and suppression jointly modulate CTL effi-
cacy in the tumor microenvironment. Conceivably, additive
cytotoxicity may contribute to the efficacy of immuno- combined
with molecular-targeted therapy.
In the B16F10/OVA melanoma model, high CTL density and
CTL migration between target cells was a prerequisite for fre-
quent CTL contacts and perforin events in the melanoma cells. By
immunotherapy, intratumor CTL density can be increased by
activation of immunostimulatory pathways57, antagonization of
inhibitory molecules expressed by tumor cells58, anti-angiogenic
therapy normalizing dysfunctional vessel endothelium59, or by
activating the tumor endothelium60. Local CTL accumulation can
further be achieved by enhancing local CTL proliferation and/or
retention by contract stabilization12. For example, additive cyto-
toxicity could underlie the reduced tumor growth in response to
combined anti-CTLA-4 and radiation therapy, which enhances
local CTL density and contact duration in breast carcinoma61.
The here observed positive correlation between contact dura-
tion and the number of delivered sublethal events suggest that the
efficacy of sublethal hit delivery may be improved by stabilizing
CTL interactions, e.g., by bispecific antibodies that connect CTL
and target cell, and facilitate repetitive hits5,62 or by agonistic
anti-CD137 antibody12. The concept of additive cytotoxicity may
further provide new rationales for CAR T- and TCR T-cell
design. Instead of designing cells with single-epitope specificity
and high individual killing capacity at the expense of “on-target/
off-tumor” side effects, higher efficacy may be achieved by
designing multiclonal CTL, which target epitope combination
and mediate less damage in individual interactions. Lastly, similar
to chemo- and radio-sensitizing approaches, tumor cell suscept-
ibility to sublethal CTL damage may be increased by combining
complementary treatment modalities to induce DNA stress. As
example, adoptive CTL transfer could be combined with DDR
inhibitors, which target members of the DNA-dependent protein
kinase or the poly(ADP-ribose) polymerase family63.
In conclusion, our data suggests that serial conjugation and
delivery of sublethal hits define the efficacy of CTL effector
function, which can be exploited by targeted immunotherapy to
increase both single-contact efficacy and cooperation of immune
effector cells.
Methods
Cell lines and primary cell culture. Mouse embryonic fibroblast-derived C57BL/6
cells (MEC-1) and MEC-1 cells expressing B7.1 and the OVA-derived CTL epitope
SIINFEKL (MEC-1/OVA) or the adenovirus type 5 E1A-derived CTL epitope
SGPSNTPPEI (MEC-1/E1A) coupled to a signal sequence, which routes the pep-
tide to the endoplasmatic reticulum, were used as target cells22,23. The cells were
maintained in RPMI 1640 medium (GIBCO, 21875-034) supplemented with
fetalcalf serum (FCS) (10%; SIGMA, F7524), HEPES (10 mM; GIBCO, 15630-056),
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2-mercaptopethanol (500 mM), penicillin and streptomycin (100 U/ml, each; PAA,
P11-010), sodium pyruvate (1 mM; GIBCO, 11360-039), and non-essential amino
acids (0.1 mM; GIBCO, 11140-035).
Mouse B16F10 melanoma cells expressed the OVA-derived CTL epitope
SIINFEKL (B16F10/OVA). B16F10/OVA cells were transduced to express histone-
2B/mCherry, as described12. Using sequential passaging, a low-pigmented subline
was derived and unchanged growth, invasion ability, antigenicity, and apoptosis
resistance in vitro and in vivo were validated. B16F10 lines were cultured in RPMI
1640 medium (GIBCO, 21875-034) supplemented with FCS (10%; SIGMA, F7524),
sodium pyruvate (1 mM; GIBCO, 13360-039), and penicillin and streptomycin
(100 U/ml each; PAA, P11-010). To increase antigenic peptide expression, B16F10/
OVA cells were stimulated with murine IFNγ (200 U/ml; PEPROTECH, 315-05)
for 48 h before co-culture with CTL.
Male HLA-A2 expressing human MV3 and BLM melanoma cells were
maintained in Dulbecco’s modified Eagle medium (GIBCO, 10938-025)
supplemented with FCS (10%; SIGMA, F7524), glutamine (2 mM; LONZA, BE17-
605), sodium pyruvate (1 mM; GIBCO, 13360-039), and penicillin and
streptomycin (100 U/ml each; PAA, P11-010). Cells were stimulated with human
IFNγ (200 U/ml; SIGMA, I3265) for 48 h prior to co-culture experiments.
The identity of B16F10, MCF-7, MV3, and BLM cells was verified by short
tandem repeat DNA profiling (IDEXX BioResearch). No respective mammalian or
mouse interspecies contamination was detected. Neativity for mycoplasma
contamination was routinely confirmed (MycoAlert, Lonza).
Mice. Mouse breeding and crossings were performed in the Central Animal
Laboratory of the Radboud University Nijmegen, The Netherlands. Mice were
housed under specific pathogen-free conditions and 12 h light/12 h dark cycles.
Four- to 6-week-old C57BL/6J mice were obtained from Charles River
Laboratories. Mice expressing transgenic enhanced green fluorescent protein
(eGFP) under the human ubiquitin C promoter (Jackson Laboratories, C57BL/6-
Tg(UBC-GFP)30Scha/J, stock number: 004353) and mice expressing transgenic
dsRed under the chicken β-actin promoter (Jackson Laboratories, STOCK C57BL/
6-Tg(CAG-DsRed*MST)1Nagy/J, stock number: 006051) were crossed to
transgenic OT1 TCR mice (Jackson Laboratories, C57BL/6-Tg(TcraTcrb)1100Mjb/
J, stock number: 003831) to breed double-transgenic eGFP/OT1 and dsRed/
OT1 mice.
C57BL/6-Prf1tm1Sdz/J mice were purchased at Jackson Laboratories (stock
number: 002407) and crossed to double-transgenic dsRed/OT1 mice. Genotyping
was performed by PCR following the genotyping protocol recommended by
Jackson Laboratory. Mice (6–10 weeks of age) homozygous for mutant perforin-1
were used for experiments.
Ex vivo isolation and activation of primary CD8+ OT1 CTL. OT1 CTL were
isolated and activated as described12. Briefly, splenocytes were isolated from OT1
or double-transgenic eGFP/OT1 or dsRed/OT1 mice. Erythrocytes were depleted
by ammonium chloride lysis buffer (0.83% NH4Cl, 0.1% KHCO3, 0.37% Na2
EDTA). Antigen-specific CTLs were obtained by splenocyte culture in 24-well
plates for 3 days, with an initial cell density of 2.5 × 105/ml in the presence of
SIINFEKL peptide (0.5 µg/ml). On day 3, cultures were supplemented with IL-2
(100 U/ml; ABD SEROTEC, PMP-38) and maintained for further 24–48 h. Cells
were collected on days 4 or 5 using Ficoll gradient centrifugation (AXIS-SHIELD
PoC AS, Oslo, Norway). Purity of activated OT1 CTL was determined by flow
cytometry and typically exceeded 96% of Vα2+CD8+ CD62LlowCD44hi cells (Vα2,
BD Bioscience 560622, 1 : 100; CD8a, BD Biosciences 551162, 1 : 100; CD62L, BD
Biosciences 553150, 1 : 100; CD44, CALTAG Laboratories RM5701-3, 1 : 100).
After 3D cytotoxicity co-culture, CTL and surviving target cells were collected
by dissolving the collagen matrix with collagenase I (40 U per 96-well; 30 min;
SIGMA C0130) and detaching adherent cells or cell clusters using trypsin/EDTA
(5min). Cell fractions were combined, washed (phosphate-buffered saline), and
stained with primary AlexaFluor488-conjugated anti-Lamp-1 rat-IgG
(BIOLEGEND, 121608, 1 : 25) or IgG Isotype control (BIOLEGEND, 400525,
1 : 25), and additional secondary AlexaFluor488-conjugated donkey anti-rat
polyclonal antibody (LIFE TECHNOLOGIES, A21208, 1 : 200). CTLs were gated
for intact morphology, viability (propidium iodide exclusion), and dsRed
expression (De Novo FCS Express 4). Cell populations were calculated using the
histogram subtraction function (FCS Express).
Activation and culture of primary human SMCY.A2 CTL. The CD8+ SMCY
CTL line was isolated and cultured as described27. Briefly, CD8+ CTL were isolated
from peripheral blood mononuclear cell (PBMC) obtained from a renal cell car-
cinoma patient who received allogeneic stem cell transplantation (SCT) and donor
lymphocyte infusions. Peripheral blood samples for investigational use were
obtained under informed consent by the patient, which was approved by the
Medical Ethics Committee of the Radboud University Medical Centre and conform
to the principles of the Declaration of Helsinki. CD8+ T cells were maintained in
Iscove’s modified Dulbecco’s medium (IMDM; INVITROGEN, Carlsbad, CA)
supplemented with human serum (10%; HS; Sanquin blood bank, Nijmegen, The
Netherlands) and expanded by weekly stimulation with PBMC obtained before
SCT. Expanded CTLs (0.5 × 106) were maintainned in IMDM/10% HS containing
irradiated (80 Gy) recipient EBV-LCL (0.5 × 106) and irradiated (60 Gy) allogeneic
PBMC (0.5 × 106) from two donors, together with IL-2 (100 IU/ml; Chiron,
Emeryville, CA) and PHA-M (1 mg/ml; Boehringer, Alkmaar, The Netherlands).
SMCY.A2-specific CTL were isolated by fluorescence-activated cell sorting (FACS),
using tetramer staining of HLA-A2-restricted SMCY.A2 epitope FIDSYICQV,
resulting in >95% purity. Specificity of SMCY.A2 CTL for the male epitope was
verified by the lack of cytotoxicity against female HLA-A2-expressing breast car-
cinoma (MCF-7) target cells (Fig. 1d).
Three-dimensional cytotoxicity CTL–target cell co-culture and time-lapse
microscopy. A sub-confluent monolayer of target cells was overlaid with a 3D
collagen gel (PureCol, concentration: 1.7 mg/ml) containing pre-activated CTL in a
24-well plate. After collagen polymerization (30 min, 37 °C), the culture was
overlaid with undiluted CTL growth medium. Cell dynamics were recorded by
bright-field time-lapse microscopy (30 s frame interval) for 24–48 h.
The duration, kinetics, and outcome of CTL–target cell interactions were
quantified by manual analysis. To distinguish CTL–target cell conjugation from
irrelevant passengers, the following criteria were used: CTLs in contact with target
cells (i) altered their migration track towards or along the target cell, (ii) slowed
migration speed, and (iii) changed morphology, such as spreading on or
polarization towards the target cell surface (Supplementary Fig. 1b). For
quantification of the frequency of serial killing, only CTLs that remained in focus
and could be followed for >12 h were analyzed. CTL–target cell interactions were
classified as nonlethal when the target cell survived for at least 3 h after CTL
detachment. The >3 h follow-up period was obtained from statistics of the time
period between last CTL-induced perforin event and target cell death, indicating
1 h in MEC-1/OVA and 1–2 h in B16F10/OVA as cutoffs. Manual analysis was
validated by at least two independent researchers as well as blinded analysis.
Detection of sublethal damage in target cells. MEC-1/OVA and B16F10/OVA
target cells were lentivirally transduced to stably express the calcium sensor
GCaMP6s29. Cells were selected for stable expression using blasticidin (10 µg/ml:
Life Technologies, R210-01) and FACS-sorted for GCaMP6s positivity. pCDH-
NLS-copGFP-EF1-BlastiS coding for the NLS-GFP31 reporter was a gift from Jan
Lammerding (Addgene plasmid #132772; http://n2t.net/addgene:132772; RRI-
D:Addgene_132772). Histone-2B-mCherry-expressing B16F10/OVA cells were
lentivirally transduced to express NLS-GFP, selected using blasticidin (10 µg/ml:
Life Technologies, R210-01) and FACS-sorted for double-positive GFP and
mCherry expression. Apple-53BP1trunc64 was a gift from Ralph Weissleder
(Addgene plasmid # 69531; http://n2t.net/addgene:69531;RRID: Addgene_69531).
B16F10/OVA cells were lentivirally transduced to stably express Apple-
53BP1trunc, selected for stable construct integration with puromycin (2 µg/ml:
Sigma-Aldrich, P7255) and FACS-sorted for Apple-positive cells. Sorted cells were
further subcloned and three clones were pooled to achieve uniform reporter
expression levels.
Time-lapse detection of sublethal damage. CTL–target cell interactions and sub-
lethal damage during interaction were detected by co-registering the fluorescent
reporter and dsRed OT1 CTL at the following frame intervals and duration: 8–12 s
for up to 12 h (GCaMP6s); 2 min for up to 30 h (NLS-GFP). For monitoring CTL
conjugation with Apple-53BP1trunc-expressing target cells, which spectrally
overlaps with dsRed2, transmission contrast of unlabeled wt OT1 CTL and
fluorescence of Apple-53BP1trunc were recorded at time intervals of 5–10 min for
up to 48 h (Leica SP8 SMD Confocal). Excitation was limited to 0.05 mW for each
excitation line (561 nm for Histone-2B-mCherry, Apple-53BP1trunc and dsRed2;
488 nm for GCaMP6s and NLS-GFP). Viability of CTL and target cells during
long-term imaging was verified by the following criteria: constant CTL migration
speed; morphological CTL integrity over time including lack cell death of multiple
cells; and unperturbed proliferation, in comparison to bright-field imaging. CTL-
associated damage events were identified by manual or semi-automated image
segmentation and intensity analysis using ImageJ/FIJI.
Ca2+ signals in OT1 CTL and target cells were monitored by spinning-disk
confocal microscopy (BD Pathway) during 3D co-culture of Fura2-labeled OT1
CTL with GCaMP6s-expressing B16F10/OVA cells, using frame rates of 95 s for
Fura2 (340/380 nm) and 8 s for GCaMP6s excitation (488 nm). To account for
phototoxicity and bleaching, imaging periods were limited to 1 h.
Intravital multiphoton microscopy. All experiments with mice were approved by
the Ethical Committee on Animal Experiments and were performed in the Central
Animal Laboratory of the Radboud University, Nijmegen (RU-DEC 2009-174,
2011-298, 2017-0034), in accordance with the Dutch Animal Experimentation Act
and the European FELASA protocol (www.felasa.eu/guidelines.php). Tumor size
was continuously monitored by fluorescence microscopy, with a humane endpoint
for tumors exceeding 1 cm3.
Histone-2B/mCherry-expressing tumor cells (1 × 105) were injected into the
deep dermis of C57/B16J mice (Charles River) carrying a dorsal skin-fold chamber,
as described12. Three days after tumor implantation, in vitro-activated dsRed OT1
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CTLs (0.5–1 × 106) were injected intravenously. Tumor-bearing mice were
repeatedly monitored for up to 15 days. Intravital multiphoton microscopy was
performed on anesthesized mice (1–3% isoflurane in oxygen). During imaging,
mice were maintained on a temperature-controlled stage (37 °C). Blood vessels
were visualized by intravenous injection of AlexaFluor750-labeled 70 kDa dextran
(2 mg/mouse; Invitrogen).
Tumor volume was obtained at consecutive time points from epifluorescence
overview images and calculated as (tumor width)2 × (tumor length) × π/6.
Intravital microscopy was performed on a customized near-infrared/infrared
multiphoton scanner (TriMScope-II, LaVision BioTec a Milteny Company,
Bielefeld, Germany), equipped with three tunable Ti:Sa (Coherent Ultra II
Titanium:Sapphire) lasers and an optical parametric oscillator. Time-lapse
recordings of CTL interactions with tumor cells were acquired by sequential
scanning of 3D tissue regions with 910 nm (GFP, Al750) and 1090 nm (mCherry,
dsRed2, second harmonic generation (SHG)) at a laser power of 30 mW (910 nm)
and 60 mW (1090 nm). The sampling rate was 1 frame/2 min and sampling periods
4–8 h. For in vivo visualization of intracellular Ca2+ intensity, 3D volumes of
250 × 250 × 100 µm were acquired by simultaneous excitation at 910 nm
(GCaMP6s, Al750; 20 mW) and 1140 nm (mCherry, dsRed2, SHG; 30 mW) with a
sampling rate of 1 frame/10–15 s for periods of 1–2 h.
Image processing and quantification. Images were processed using Fiji/ImageJ
(version 1.51)65 (http://pacific.mpi-cbg.de/wiki/index.php/Fiji). Images were stit-
ched to mosaics using the Stitch Grid/Collection plugin and field drifts during
time-lapse recording were corrected using the StackReg plugin and the Correct 3D
Drift plugin. For image quantifications, the raw, unmodified images were used. For
display purposes, time-lapse recordings were adjusted for bleaching using histo-
gram normalization (Bleach Correction plugin). Background noise was filtered
using the Remove Outliners plugin and images were scaled and adjusted for
brightness, contrast, and gamma, to enhance visualization.
Intact vs. apoptotic tumor nuclei and CTLs were quantified for each individual
image section from 3D stacks of 350 × 350 µm and an imaging depth of up to
300 µm (7 µm distance between sections). To preclude repeated counting of the
same cell, every third slice per stack was analyzed. Nuclei and CTLs were
segmented by Gaussian Blur filtering, automated thresholding (Li algorithm) and
Watershed separation of touching objects. Objects were filtered for size (Nuclei:
≥60 µm2; CTL: ≥50 µm2) using the Analyze Particles command and counted per
slice. To determine apoptosis and mitosis rates from in vivo samples, apoptotic and
mitotic nuclei were counted manually and calculated as the percentage of total
nuclei per slice. Tumor subregions were defined manually, as follows: “invasion”
for cells outside of the tumor main mass; “edge” for cells located in the tumor mass
within 250 µm from the tumor–stroma interface; and “core” for cells located
>250 µm from the tumor margin (Supplementary Fig. 5d).
53BP1trunc-Apple foci were analyzed using custom scripts to segment nuclei
based on Hoechst counterstaining, followed by the detection and counting of foci
per nucleus in the Apple Channel using the Find Maxima plugin in FIJI/ImageJ.
NLS-GFP leakage events were quantified by manual tracking of the tumor nuclei
using the Manual Tracking Plugin. The intensity of nuclear GFP was divided by the
H2B-mCherry signal to correct for mild focus drifts, which affect GFP intensity.
Normalized GFP values per nucleus were plotted over time and analyzed manually for
leakage events, in combination with manual inspection of the time-lapse recording.
Statistical modeling. Target cell survival, perforin events and the resulting survival
probability curves were analyzed using the “survival” and “rms” packages in GNU
R. Redundant Ca2+-positive perforin events, which may coincide with a directly
preceding lethal hit and be misleadingly interpreted as prior, additive hits, were
removed, based on the following considerations. The “stochastic killing” hypothesis
predicts perforin events to be equally likely to induce apoptosis; therefore, the
number of perforin events received prior to the last event preceding apoptosis is
not expected to reduce target cell survival. Conversely, redundant perforin events,
which are dispensable for apoptosis, may be induced in rapid sequence by the same
or other CTL after the final lethal event was received by the target cell. Such
redundant events may result in an overestimation of required hits. To remove such
possibly redundant events, we used the following approach. The intervals between
the last lethal event and apoptosis were assumed as exponentially distributed, and
the mean waiting time was fitted using the maximum likelihood method to
describe the data with highest fidelity. The perforin event with highest likelihood of
being the terminal event was determined using the fitted distribution. This event
was defined as the terminal event, with subsequent perforin events considered as
redundant. Despite removing redundant contacts, the survival probability and lag
times to apoptosis remained significantly dependent on prior perforin events
(p= 0.00032 with removal, p= 0.00003 without) (Supplementary Fig. 5b).
To simulate stochastic killing, the intervals between perforin events and the lag
time between the last perforin event to apoptosis were randomly permuted.
Assuming stochastic killing, these permutations are not expected to impact target
cell survival probability. However, the permuted data resulted in significantly
enhanced killing efficiency compared to the actual killing efficiency derived from
live-cell measurements, and the amount of perforin events preceding the final event
lacked impact on survival probability (Fig. 5c).
Cell damage repair times were estimated from the perforin event data in target
cells using a Cox proportional hazards model based on the following assumptions:
(1) each perforin event induces a unit amount of damage to the cell; (2) existing
damage decays exponentially; (3) the instantaneous risk of apoptosis (hazard) is
proportional to the current amount of damage. The damage was entered into the
model as a time-dependent covariate and its coefficient represents the amount of
damage dealt by each hit. The decay rate of the exponential function was then
estimated by minimizing the negative log-likelihood of the model.
Statistical analysis. Unpaired Student’s t-tests or Mann–Whitney U-tests, as
appropriate, were applied using GraphPad Prism 8.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Further information and requests for resources and reagents should be directed to and
will be fulfilled by the corresponding authors. Source data are provided with this paper.
Material availability
This study did not generate new unique reagents. Source data are provided with
this paper.
Code availability
The analysis of the perforin-mediated Ca2+ time-to-event data was performed using the
R platform for statistical computing, with some preprocessing performed in Python. The
R and Python code used for the statistical analysis and simulations of the Ca2+ data can
be found at https://github.com/jtextor/2020-ctl-killing.
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